World's Best Scientists 2026 revealed!
Julian Grosskreutz

Julian Grosskreutz

D-Index & Metrics

Neuroscience

D-Index
52
Citations
10283
World Ranking
5313
National Ranking
448

Julian Grosskreutz publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Julian Grosskreutz sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 232 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Julian Grosskreutz D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Julian Grosskreutz sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 52 D-Index — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Julian Grosskreutz is affiliated with the University of Lübeck in Germany and has contributed extensively to medical research, with a primary focus on neurology. Their work spans multiple subfields including neurology, genetics, molecular biology, psychiatry and mental health, and surgery. The predominant area of study, as reflected in their publication record, is amyotrophic lateral sclerosis (ALS) research.

The scientist's research topics cover a range of neurological disorders and mechanisms. Key themes in their work include:

  • Amyotrophic Lateral Sclerosis Research
  • Neurogenetic and Muscular Disorders Research
  • Parkinson's Disease Mechanisms and Treatments
  • Myasthenia Gravis and Thymoma
  • Prion Diseases and Protein Misfolding
  • Neurological diseases and metabolism
  • Alzheimer's disease research and treatments

Julian Grosskreutz has frequently published in several specialized journals. The notable publication venues with their respective number of publications are:

  • Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (11 publications)
  • Clinical Neurophysiology (7 publications)
  • Neurological Research and Practice (7 publications)
  • Journal of Neurology Neurosurgery & Psychiatry (7 publications)
  • Nervenheilkunde (7 publications)

The scientist has collaborated with several frequent coauthors. These colleagues include:

  • Robert Steinbach
  • Susanne Petri
  • Thomas Meyer
  • Ute Weyen
  • Torsten Grehl

Recent representative papers authored or coauthored by Julian Grosskreutz include:

  • A proposal for new diagnostic criteria for ALS, 2020, Clinical Neurophysiology
  • Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study, 2023, The Lancet Neurology
  • Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis, 2022, JAMA Neurology
  • Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis, 2021, Nature Neuroscience
  • Effects of tofersen treatment in patients with SOD1-ALS in a "real-world" setting - a 12-month multicenter cohort study from the German early access program, 2024, EClinicalMedicine

The published works cover a range of clinical and translational studies related mainly to ALS and related neurological conditions. These studies often address diagnostic criteria, prognostic biomarkers, therapeutic efficacy, and safety assessments in patient populations.

Best Publications

  • Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

    Wouter van Rheenen;Aleksey Shatunov;Annelot M. Dekker;Russell L. McLaughlin

  • A proposal for new diagnostic criteria for ALS

    Jeremy M. Shefner;Ammar Al-Chalabi;Mark R. Baker;Li-Ying Cui

  • Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model

    Henk Jan Westeneng;Thomas P.A. Debray;Anne E. Visser;Ruben P.A. van Eijk

  • The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons

    Helmuth Adelsberger;Stefan Quasthoff;Julian Grosskreutz;Alexandra Lepier

  • Calcium dysregulation in amyotrophic lateral sclerosis

    Julian Grosskreutz;Ludo Van Den Bosch;Bernhard U. Keller

  • Hot-spot KIF5A mutations cause familial ALS

    David Brenner;Rüstem Yilmaz;Kathrin Müller;Torsten Grehl

  • Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease.

    Koen Poesen;Maxim De Schaepdryver;Beatrice Stubendorff;Benjamin Gille

  • Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis

    Emily Feneberg;Patrick Oeckl;Petra Steinacker;Federico Verde

  • Prefrontal and anterior cingulate cortex abnormalities in Tourette Syndrome: evidence from voxel-based morphometry and magnetization transfer imaging

    Kirsten R Müller-Vahl;Jörn Kaufmann;Julian Grosskreutz;Reinhard Dengler

  • Voltage-dependent block of neuronal and skeletal muscle sodium channels by thymol and menthol.

    G. Haeseler;D. Maue;J. Grosskreutz;J. Bufler

  • Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis

    Julian Grosskreutz;Jörn Kaufmann;Julia Frädrich;Reinhard Dengler

  • A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis.

    Hans Peter Müller;Martin R. Turner;Julian Grosskreutz;Sharon Abrahams

  • Towards a neuroimaging biomarker for amyotrophic lateral sclerosis.

    Martin R Turner;Julian Grosskreutz;Jan Kassubek;Sharon Abrahams

  • Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis.

    Albert C Ludolph;Albert C Ludolph;Johannes Dorst;Jens Dreyhaupt;Jochen H Weishaupt

  • The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis.

    Vedrana Tadic;Tino Prell;Janin Lautenschlaeger;Julian Grosskreutz

  • Calcium potentials and tetrodotoxin-resistant sodium potentials in unmyelinated C fibres of biopsied human sural nerve

    S. Quasthoff;J. Grosskreutz;J.M. Schröder;U. Schneider

  • Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis.

    Iddo Magen;Nancy Sarah Yacovzada;Eran Yanowski;Anna Coenen-Stass;Anna Coenen-Stass

  • Assessment of the upper motor neuron in amyotrophic lateral sclerosis

    William Huynh;William Huynh;Neil G. Simon;Julian Grosskreutz;Martin R. Turner

  • Muscle ultrasonography as an additional diagnostic tool for the diagnosis of amyotrophic lateral sclerosis

    A. Grimm;T. Prell;B.F. Décard;U. Schumacher

  • Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.

    Christian Lersch;Renate Schmelz;Florian Eckel;Johannes Erdmann

  • Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis

    Carsten Keil;Tino Prell;Thomas Peschel;Viktor Hartung

  • Common and rare variant association analyses in Amyotrophic Lateral Sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

    Wouter van Rheenen;Rick A. A. van der Spek;Mark K. Bakker;Joke J. F. A. van Vugt

Frequent Co-Authors

Otto W. Witte
Otto W. Witte Friedrich Schiller University Jena
Albert C. Ludolph
Albert C. Ludolph University of Ulm
Martin R. Turner
Martin R. Turner University of Oxford
Mamede de Carvalho
Mamede de Carvalho University of Lisbon
Peter M Andersen
Peter M Andersen Umeå University
Jan Kassubek
Jan Kassubek University of Ulm
Reinhard Dengler
Reinhard Dengler Hanover University of Applied Sciences and Arts
Michael Swash
Michael Swash Queen Mary University of London
Orla Hardiman
Orla Hardiman Trinity College Dublin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience in the USA opens up diverse career options and pathways for further education. Many students combine neuroscience with psychology to broaden their expertise. For those interested in a clinical track, pursuing online psyd programs can lead to advanced roles in research, therapy, or counseling.

Another pathway is through marriage and family therapy. The flexibility of mft accredited programs online allows you to gain specialized skills that complement neuroscience training, opening doors in mental health services.

For those eager to enter the workforce sooner, accelerated degrees online offer the ability to complete your education efficiently. This is especially valuable for students balancing work or family commitments.

When considering long-term career goals, selecting the most valuable degree in the world aligned with your interests can make a significant impact on your earning potential. Pairing a neuroscience background with in-demand credentials ensures versatile career opportunities in healthcare, research, and technology.

Best Scientists Citing Julian Grosskreutz

Trending Scientists

Recently Published Articles